Dow Jones

38 834,86

0,15%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Synergy Pharmaceuticals, Inc. (MM) (SGYPD)
Synergy Pharmaceuticals, Inc. (MM) (SGYPD) Actualités

SGYPD

Synergy Pharmaceuticals, Inc. (MM) (SGYPD)

Synergy Pharmaceuticals, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:SGYPD

Date	Heure	Source	Titre	Symbole	Société
02/03/2019	01h13	Dow Jones News	Synergy Pharmaceuticals Is Approved to Sell Assets to Bausch Health	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
27/02/2019	01h07	Dow Jones News	Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
17/12/2018	21h43	Dow Jones News	Synergy Pharmaceuticals Up 55% on Trulance Progress in Canada	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
12/12/2018	17h10	Dow Jones News	Former Pharma Highflier Appreciates Bathroom Humor -- Overheard	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
12/12/2018	14h18	Dow Jones News	Bausch Health to Buy Synergy Pharmaceuticals Out of Bankruptcy for $200 Million--Update	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
12/12/2018	13h14	Dow Jones News	Bausch Health Agrees to Buy Synergy Pharmaceuticals for $200 Million	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
03/01/2012	22h44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
27/12/2011	22h05	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
22/12/2011	12h01	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
21/12/2011	18h18	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
19/12/2011	23h04	Edgar (US Regulatory)	Securities Registration Statement (simplified form) (S-3/A)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
13/12/2011	22h41	Business Wire	Synergy Pharmaceuticals Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
13/12/2011	14h00	PR Newswire (US)	Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior V...	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
13/12/2011	09h00	Business Wire	Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. & its Chief Scientific Officer & Senior VP of...	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
06/12/2011	23h00	Business Wire	Synergy Pharmaceuticals Announces Closing of Public Offering of 1,875,000 Units	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
01/12/2011	23h14	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(2) (424B2)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
01/12/2011	14h00	Business Wire	Synergy Pharmaceuticals Inc. Announces Pricing of Public Offering of 1,875,000 Units, Listing on NASDAQ & Effectiveness of Re...	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)